MedTrace Logo

Bone Response to Soy Isoflavones in Women

NCT00043745 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2013-02-07

No results posted yet for this study

Summary

This study will provide valuable data on whether soy isoflavones impact bone loss in postmenopausal women. The study will help clarify potential mechanisms and contribute to our understanding of isoflavones as an alternative to traditional hormone therapy.

Conditions

Interventions

DIETARY_SUPPLEMENT

Soy isoflavones

Soy isoflavones extracted from soy protein, compressed into tablets; three tablets taken daily

DIETARY_SUPPLEMENT

Extract tablets

Extract from soy protein, but devoid of isoflavones; three tablets taken once daily

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Iowa State University

    lead OTHER

Principal Investigators

  • D. Lee Alekel, PhD · Iowa State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2008-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00043745 on ClinicalTrials.gov